The Welcome to Symptomatic. Today we are tackling prostate cancer, the most common cancer men face,

something one in eight men will navigate during the course of their lifetime, which also has a ripple

effect on their friends and family. And we're recording this episode from the 2024 ASCO, American

Society of Clinical Oncology Annual Meeting. I am joined by a gentleman today,

ideally suited for this complicated conversation. Dr. Muhammad Atik is an assistant professor

in the Department of Medicine at University of Chicago Medicine, where he specializes in

hematology and oncology with a focus on geniturinary cancers.

His research has appeared in leading publications and has earned him recognition as an American

College of Physicians Young Achiever and a Prostate Cancer Foundation young investigator.

Welcome, Dr. Attee.

Thank you. Thank you. Happy to be here. Now, right out of the gate,

what drew you to this specialty? Yeah, so it really kind of started out. My father's medical

oncologist, and so when I was younger, my siblings and I would kind of go into the clinic,

maybe help out there. And we grew up in a small town in Arkansas. We really got to see the

development of the relations that he had with his patients. And so that development of relations

was something that we always kind of grew to admire. But for myself, it was really, I began to

learn more about molecular biology and genetics and getting into that, I became

fascinated with the science behind cancer.

And so as I went through medical school, I knew that I wanted to do something with it.

I just didn't know in what shape.

And so I just kind of found myself gravitating more and more towards medical oncology.

As I finished residency and I was kind of looking myself gravitating more and more towards medical oncology. As I finished residency

...